Potentiation of adrenal medullary responses to angiotensin by (4,4'-biphenylenebis-(2-oxoethylene)) bis((2,2-diethoxyethyl)-dimethylammonium bromide) (DMAE) in vitro.
D000313:Adrenal Medulla / Q000187:drug effects* / Q000378:metabolism; D000661:Amphetamine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004347:Drug Interactions; D004357:Drug Synergism; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008688:Methacholine Compounds / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D010477:Perfusion; D011189:Potassium Chloride / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology
D001713:Biphenyl Compounds; D002395:Catecholamines; D008688:Methacholine Compounds; D000644:Quaternary Ammonium Compounds; D013566:Sympathomimetics; D013757:Tetraethylammonium Compounds; D000804:Angiotensin II; D004246:Dimethylphenylpiperazinium Iodide; D011189:Potassium Chloride; D009538:Nicotine; D001285:Atropine; D006632:Histamine; D000661:Amphetamine; D001920:Bradykinin